共 142 条
[21]
Ito MK(2004)Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double blind, controlled trial Clin Ther 26 1599-1607
[22]
Bestermann W(2007)Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002 Circulation 115 1363-1370
[23]
Houston MC(2006)Insufficient treatment of hypercholesterolemia among patients hospitalized with chest pain Clin Cardiol 29 259-262
[24]
Basile J(2006)What the statin trials have taught us Am J Cardiol 98 129-134
[25]
Egan B(2007)Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction Diabetes Care 30 479-484
[26]
Ferrario CM(2007)Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol Am J Cardiol 100 1499-1501
[27]
Lackland D(2005)Gauging the treatment gap in dyslipidemia: findings from the 1999–2000 National Health and Nutrition Examination Survey Am Heart J 150 595-601
[28]
Hawkins RG(2006)Differences between clinical trial efficacy and real-world effectiveness Am J Manag Care 12 S405-S411
[29]
Reed J(2006)How safe is aggressive statin therapy? Prog Cardiovasc Nurs 21 140-145
[30]
Rogers P(2002)The new cholesterol guidelines. Applying them in clinical practice Postgrad Med 112 13-16